New medicines, better medicines, better use of medicines
Pharmaceutical science in the UK has a long and excellent record of medicines research and development, being at the forefront of many major advances in modern medicines and their use.
The guide, New Medicines, Better Medicines, Better Use of Medicines, developed by the Society’s Pharmaceutical Science Expert Advisory Panel, summarises the important role pharmacists and pharmaceutical scientists have played and continue to play in the development and use of medicines. It highlights the major challenges and opportunities faced when creating new medicines, improving existing medicines or ensuring the better, safer, use of medicines. The guide contains seven recommendations arising from the challenges, and which identify areas for development, expansion, change and innovation for the future.
Ensuring the safe use of medicines
Increasing understanding of the causes of medication errors and the impact of pharmacy interventions and improving awareness of patients and the public of the risks and benefits of taking medicines.
Educating the public, patients and current and future healthcare professionals on the place of antimicrobial treatment and non-medical infection control interventions.
Adopting new technologies
Educating the public and patients about the ethical and moral issues surrounding the use of new technologies such as stratified medicine, gene therapy, regenerative medicine, therapeutic vaccines and biomarkers.
Supporting the development of new medicines
Facilitating the supply of new and innovative medicines, by reducing the cost and time to bring these medicines to the market.
Increasing the evidence base for pharmacy
Supporting the development of an improved evidence base to enable pharmacists to optimise the care of patients and the public and increasing the research capacity and capability within the profession
Supporting pharmaceutical science in the UK
Ensuring that the UK remains a major player in the development of new and innovative medicines by expanding current Government initiatives aimed at making the UK an attractive location for companies of all sizes to base their activities, as well as increasing support for more academic/NHS/industrial partnerships.
Improving access to medicines at a global level
Supporting the responsible re-use of medicines to improve access to medicines in developing world communities thereby improving health.